Antibodies to SARS-CoV-2 and risk of past or future sick leave

The extent that antibodies to SARS-CoV-2 may protect against future virus-associated disease is unknown. We invited all employees (n = 15,300) at work at the Karolinska University Hospital, Stockholm, Sweden to participate in a study examining SARS-Cov-2 antibodies in relation to registered sick lea...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Sci Rep
Glavni autori: Dillner, Joakim, Elfström, K. Miriam, Blomqvist, Jonas, Eklund, Carina, Lagheden, Camilla, Nordqvist-Kleppe, Sara, Hellström, Cecilia, Olofsson, Jennie, Andersson, Eni, Jernbom Falk, August, Bergström, Sofia, Hultin, Emilie, Pin, Elisa, Månberg, Anna, Nilsson, Peter, Hedhammar, My, Hober, Sophia, Mattsson, Johan, Mühr, Laila Sara Arroyo, Conneryd Lundgren, Kalle
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933367/
https://ncbi.nlm.nih.gov/pubmed/33664279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84356-w
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items